William G. Kerr

6.8k total citations · 2 hit papers
109 papers, 5.2k citations indexed

About

William G. Kerr is a scholar working on Immunology, Molecular Biology and Hematology. According to data from OpenAlex, William G. Kerr has authored 109 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Immunology, 45 papers in Molecular Biology and 25 papers in Hematology. Recurrent topics in William G. Kerr's work include Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (26 papers) and PI3K/AKT/mTOR signaling in cancer (23 papers). William G. Kerr is often cited by papers focused on Immune Cell Function and Interaction (30 papers), T-cell and B-cell Immunology (26 papers) and PI3K/AKT/mTOR signaling in cancer (23 papers). William G. Kerr collaborates with scholars based in United States, France and Netherlands. William G. Kerr's co-authors include Leonard A. Herzenberg, Steve Fiering, Philippe Soriano, Akira Imamoto, Brian Zambrowicz, John D. Chisholm, Richard Jove, Hua Yu, James J. Mulé and Kim H.T. Paraiso and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

William G. Kerr

102 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity

2005 813 citations James J. Mulé, William G. Kerr et al. profile →
Disruption of overlapping transcripts in the ROSA βgeo 26 gene trap strain leads to widespread expression of β-galactosidase in mouse embryos and hematopoietic cells

1997 729 citations William G. Kerr et al. profile →

Peers

Countries citing papers authored by William G. Kerr

Since Specialization

Citations

This map shows the geographic impact of William G. Kerr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Kerr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Kerr more than expected).

Fields of papers citing papers by William G. Kerr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William G. Kerr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Kerr. The network helps show where William G. Kerr may publish in the future.

Co-authorship network of co-authors of William G. Kerr

This figure shows the co-authorship network connecting the top 25 collaborators of William G. Kerr. A scholar is included among the top collaborators of William G. Kerr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William G. Kerr. William G. Kerr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Aminocholestane and Aminoandrostane Inhibitors of the SH2 Domain‐Containing Inositol 5’‐Phosphatase (SHIP) 2025 ·ChemMedChem ·(unknown), (unknown), (unknown), Sandra Fernandes, (unknown), (unknown), (unknown), Raki Sudan, (unknown), Christopher M. Russo, (unknown), Michael S. Cosgrove, William G. Kerr, John D. Chisholm	0
2	Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma 2024 ·Rhinology Journal ·Joaquim Mullol, Vibeke Backer, Jannis Constantinidis, Ibon Eguíluz‐Gracia, Abraham L. Moure, (unknown), Lingjiao Zhang, Pallav L. Shah, William G. Kerr, Peter W. Hellings	2
3	Microglial lipid phosphatase SHIP1 limits complement-mediated synaptic pruning in the healthy developing hippocampus 2024 ·Immunity ·(unknown), (unknown), (unknown), (unknown), Andranik Ivanov, (unknown), Gwenaël Labouèbe, Loredana Leggio, (unknown), Dieter Beule, Virginie Mansuy‐Aubert, Timothy L. Williams, Nunzio Iraci, Amanda Sierra, Samuele Marro, Alison Goate, Bart J. L. Eggen, William G. Kerr, Rosa Chiara Paolicelli	8
4	SHIP1 inhibition via 3-alpha-amino-cholestane enhances protection against Leishmania infection 2023 ·Cytokine ·(unknown), Shibali Das, (unknown), Surya Prakash Pandey, Raki Sudan, Neetu Srivastava, John D. Chisholm, William G. Kerr, Subrata Majumdar, Bhaskar Saha	4
5	Overexpression of SH2-Containing Inositol Phosphatase Contributes to Chronic Lymphocytic Leukemia Survival 2019 ·The Journal of Immunology ·Simar Pal Singh, Marjolein J. W. de Bruijn, (unknown), Odilia B. J. Corneth, Jasper Rip, Ralph Stadhouders, Ruud W. J. Meijers, Stéphane Schurmans, William G. Kerr, (unknown), Eric Eldering, Anton W. Langerak, (unknown), Rudi W. Hendriks	5
6	Dual enhancement of T and NK cell function by pulsatile inhibition of SHIP1 improves antitumor immunity and survival 2017 ·Science Signaling ·Matthew Gumbleton, Raki Sudan, Sandra Fernandes, Robert W. Engelman, Christopher M. Russo, John D. Chisholm, William G. Kerr	31
7	A small-molecule inhibitor of SHIP1 reverses age- and diet-associated obesity and metabolic syndrome 2016 ·JCI Insight ·Neetu Srivastava, Sonia Iyer, Raki Sudan, C. G. Youngs, Robert W. Engelman, (unknown), Christopher M. Russo, John D. Chisholm, William G. Kerr	26
8	SHIP1 Regulates MSC Numbers and Their Osteolineage Commitment by Limiting Induction of the PI3K/Akt/β-Catenin/Id2 Axis 2014 ·Stem Cells and Development ·Sonia Iyer, (unknown), John D. Chisholm, Bryan S. Margulies, William G. Kerr	18
9	SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells 2010 ·The Journal of Immunology ·Robert W. Brooks, Gwenny M. Fuhler, Sonia Iyer, Michelle J. Smith, Mi-Young Park, Kim H.T. Paraiso, Robert W. Engelman, William G. Kerr	107
10	SHIP Influences Signals from CD48 and MHC Class I Ligands That Regulate NK Cell Homeostasis, Effector Function, and Repertoire Formation 2010 ·The Journal of Immunology ·Nicole Fortenbery, Kim H.T. Paraiso, Masaru Taniguchi, Colin G. Brooks, (unknown), William G. Kerr	23
11	SHIP limits immunoregulatory capacity in the T-cell compartment 2009 ·Blood ·Michelle Collazo, (unknown), Kim H.T. Paraiso, (unknown), Robert W. Engelman, (unknown), Diana Stauch, Katja Kotsch, William G. Kerr	51
12	Induced SHIP Deficiency Expands Myeloid Regulatory Cells and Abrogates Graft-versus-Host Disease 2007 ·The Journal of Immunology ·Kim H.T. Paraiso, Tomar Ghansah, (unknown), Robert W. Engelman, William G. Kerr	57
13	Inappropriate Recruitment and Activity by the Src Homology Region 2 Domain-Containing Phosphatase 1 (SHP1) Is Responsible for Receptor Dominance in the SHIP-Deficient NK Cell 2007 ·The Journal of Immunology ·Joseph Wahle, Kim H.T. Paraiso, Robert D. Kendig, Harshani R. Lawrence, (unknown), (unknown), William G. Kerr	42
14	s-SHIP Associates with Receptor Complexes Essential for Pluripotent Stem Cell Growth and Survival 2006 ·Stem Cells and Development ·Caroline Desponts, John M. Ninos, William G. Kerr	13
15	Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets 2006 ·The Journal of Immunology ·Joseph Wahle, Kim H.T. Paraiso, (unknown), (unknown), Charles L. Sentman, William G. Kerr	30
16	Expansion of Myeloid Suppressor Cells in SHIP-Deficient Mice Represses Allogeneic T Cell Responses 2004 ·The Journal of Immunology ·Tomar Ghansah, Kim H.T. Paraiso, Steven L. Highfill, Caroline Desponts, (unknown), (unknown), (unknown), John M. Ninos, Jason Brayer, Fengdong Cheng, Eduardo M. Sotomayor, William G. Kerr	87
17	Expression of individual immunoglobulin genes occurs in an unusual system consisting of multiple independent loci 2004 ·European Journal of Immunology ·(unknown), Ronda T. Litman, Carl A. Luer, William G. Kerr, Gary W. Litman	31
18	Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow Transplantation 2002 ·Science ·(unknown), (unknown), Tomar Ghansah, Caroline Desponts, John M. Ninos, (unknown), Kim Nguyen, Noriko Toyama‐Sorimachi, William G. Kerr	138
19	Identification of a Novel Lipopolysaccharide-Inducible Gene with Key Features of Both a Kinase Anchor Proteins and chs1/beige Proteins 2001 ·The Journal of Immunology ·Jiawang Wang, (unknown), Edward Haller, William G. Kerr	80
20	A Rapid and Quantitative Assay to Estimate Gene Transfer into Retrovirally Transduced Hematopoietic Stem/Progenitor Cells Using a 96-Well Format PCR and Fluorescent Detection System Universal for MMLV-Based Proviruses 1996 ·Human Gene Therapy ·(unknown), (unknown), Gregg P. Solar, James J. Mulé, William G. Kerr	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact